• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.27% Nasdaq Up 0.66%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    3.24 Up 0.05(1.64%) 12:59PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.19
    Open:3.14
    Bid:3.21 x 1000
    Ask:3.24 x 200
    1y Target Est:24.00
    Beta:1.25
    Next Earnings Date:N/A
    Day's Range:3.14 - 3.34
    52wk Range:3.00 - 19.11
    Volume:80,404
    Avg Vol (3m):152,959
    Market Cap:71.73M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GALT

    Comparison

    Symbol% ChgMkt Cap
    GALTUp 1.64%71.73M
    MNTAUp 3.77%611.34M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.90
    Quarterly EPS Est (Dec-14) :-0.22
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback